OUCh. On the hunt again. Sure didn't think I would see it this low.
Need to dig a bit deeper. See what the conference call reveals.
"Nuvectra (NVTR) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.84 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -27.69%. A quarter ago, it was expected that this medical device company would post a loss of $0.80 per share when it actually produced a loss of $0.65, delivering a surprise of 18.75%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Nuvectra, which belongs to the Zacks Medical - Instruments industry, posted revenues of $11.13 million for the quarter ended March 2019, missing the Zacks Consensus Estimate by 12.79%. This compares to year-ago revenues of $10.57 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Nuvectra shares have lost about 42.2% since the beginning of the year versus the S&P 500's gain of 17.5%."
